AMICUS THERAPEUTICS, INC. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMICUS THERAPEUTICS, INC. for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 21.84 | 8,794 | 192,017 | 220,705 | 229.5 K to 220.7 K (-3.83 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 20,731 | 0 | 229,499 | 208.8 K to 229.5 K (+9.93 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 21.84 | 4,770 | 104,153 | 259,370 | 264.1 K to 259.4 K (-1.81 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 9,502 | 0 | 264,140 | 254.6 K to 264.1 K (+3.73 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 21.84 | 9,960 | 217,477 | 428,116 | 438.1 K to 428.1 K (-2.27 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 22,458 | 0 | 438,076 | 415.6 K to 438.1 K (+5.40 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 86,557 | |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 21.51 | 50,000 | 1,075,325 | 859,388 | 909.4 K to 859.4 K (-5.50 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.24 | 22,000 | 489,368 | 909,388 | 931.4 K to 909.4 K (-2.36 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 931,388 | 909.4 K to 931.4 K (+2.42 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 21.84 | 31,608 | 690,161 | 909,388 | 941 K to 909.4 K (-3.36 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 80,327 | 0 | 940,996 | 860.7 K to 941 K (+9.33 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 21.84 | 14,463 | 315,800 | 378,857 | 393.3 K to 378.9 K (-3.68 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 29,367 | 0 | 393,320 | 364 K to 393.3 K (+8.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 21.78 | 185,585 | 4,042,041 | 185,585 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 115,240 | 0 | 860,669 | 745.4 K to 860.7 K (+15.46 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.17 | 7,500 | 166,305 | 745,429 | 752.9 K to 745.4 K (-1.00 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 19,994 | 461,661 | 752,929 | 772.9 K to 752.9 K (-2.59 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 22,968 | 530,331 | 772,923 | 795.9 K to 772.9 K (-2.89 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 11,335 | 261,725 | 795,891 | 807.2 K to 795.9 K (-1.40 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 16,287 | 376,067 | 807,226 | 823.5 K to 807.2 K (-1.98 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Option Exercise | A | 21.78 | 53,355 | 1,162,072 | 53,355 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 33,131 | 0 | 208,768 | 175.6 K to 208.8 K (+18.86 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 8,306 | 191,786 | 175,637 | 183.9 K to 175.6 K (-4.52 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 6,475 | 149,508 | 183,943 | 190.4 K to 183.9 K (-3.40 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 4,751 | 109,701 | 190,418 | 195.2 K to 190.4 K (-2.43 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 21.78 | 16,963 | 369,454 | 16,963 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 10,533 | 0 | 26,255 | 15.7 K to 26.3 K (+67.00 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 23.09 | 1,413 | 32,626 | 15,722 | 17.1 K to 15.7 K (-8.25 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 21.78 | 55,675 | 1,212,602 | 55,675 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 34,572 | 0 | 415,618 | 381 K to 415.6 K (+9.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 8,938 | 206,378 | 381,046 | 390 K to 381 K (-2.29 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 14,358 | 331,526 | 389,984 | 404.3 K to 390 K (-3.55 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 5,340 | 123,301 | 404,342 | 409.7 K to 404.3 K (-1.30 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 21.78 | 44,076 | 959,975 | 44,076 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 27,369 | 0 | 157,506 | 130.1 K to 157.5 K (+21.03 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 23.09 | 10,974 | 253,390 | 130,137 | 141.1 K to 130.1 K (-7.78 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 21.78 | 53,355 | 1,162,072 | 53,355 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 33,131 | 0 | 254,638 | 221.5 K to 254.6 K (+14.96 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 5,053 | 116,674 | 221,507 | 226.6 K to 221.5 K (-2.23 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 15,164 | 350,137 | 226,560 | 241.7 K to 226.6 K (-6.27 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 2,620 | 60,496 | 241,724 | 244.3 K to 241.7 K (-1.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 21.78 | 92,792 | 2,021,010 | 92,792 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,514 | 67,815 | 48,679 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 57,620 | 0 | 363,953 | 306.3 K to 364 K (+18.81 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 22.17 | 10,514 | 233,125 | 306,333 | 316.8 K to 306.3 K (-3.32 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,514 | 67,815 | 316,847 | 306.3 K to 316.8 K (+3.43 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 13,974 | 322,660 | 306,333 | 320.3 K to 306.3 K (-4.36 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 26,908 | 621,306 | 320,307 | 347.2 K to 320.3 K (-7.75 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 7,617 | 175,877 | 347,215 | 354.8 K to 347.2 K (-2.15 %) |